Prostatis Group’s RTX Corp RTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65M Sell
8,544
-81
-0.9% -$16.1K 0.42% 57
2025
Q4
$1.58M Buy
8,625
+2,152
+33% +$374K 0.38% 55
2025
Q3
$1.08M Sell
6,473
-73
-1% -$11.3K 0.27% 73
2025
Q2
$956K Sell
6,546
-45
-0.7% -$6K 0.27% 75
2025
Q1
$873K Buy
6,591
+353
+6% +$44.8K 0.28% 73
2024
Q4
$722K Buy
6,238
+1,338
+27% +$162K 0.21% 84
2024
Q3
$594K Sell
4,900
-432
-8% -$49.3K 0.19% 85
2024
Q2
$535K Sell
5,332
-50
-0.9% -$5.17K 0.19% 93
2024
Q1
$525K Sell
5,382
-22
-0.4% -$1.99K 0.2% 91
2023
Q4
$455K Buy
5,404
+589
+12% +$46.6K 0.19% 88
2023
Q3
$347K Sell
4,815
-354,840
-99% -$30.4M 0.17% 76
2023
Q2
$421K Buy
+359,655
New +$35.2M 0.2% 77
2023
Q1
Sell
-4,316
Closed -$436K 109
2022
Q4
$436K Buy
+4,316
New +$406K 0.27% 68

Other funds holding RTX

Prostatis Group's RTX Position: Q1 2026 in Review

Prostatis Group reduced its RTX Corp (RTX) stake by 0.94% in Q1 2026, selling an estimated $16.1K and leaving 8,544 shares worth $1.65M. The position accounts for 0.42% of the portfolio, ranked #57.

Prostatis Group first reported a position in RTX in Q4 2022 and has held it in 13 quarters since. 3,453 funds tracked by Wall St. Rank hold RTX as of Q1 2026.

  • Prostatis Group held 8,544 shares of RTX Corp worth $1.65M as of Q1 2026.
  • Prostatis Group sold 81 RTX Corp shares in Q1 2026, an estimated $16.1K.
  • RTX Corp made up 0.42% of Prostatis Group's portfolio in Q1 2026, its #57 holding.
  • Prostatis Group first reported a position in RTX Corp in Q4 2022 and has held it in 13 quarters since.
  • 3,453 funds tracked by Wall St. Rank held RTX Corp as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.